paclitaxel has been researched along with Pituitary Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hotta, K; Iwaki, N; Kiura, K; Kubo, T; Minami, D; Morichika, D; Sato-Hisamoto, A; Takata, K; Tanimoto, M; Uchida, K | 1 |
Inata, J; Kai, T; Kuraoka, T; Miyazaki, K; Murai, H; Tomoda, Y; Yamaoka, N | 1 |
Fangusaro, J; Finlay, J; Rook, J; Rosser, T | 1 |
McIlroy, PJ; Patel, SA; Ravindra, R | 1 |
Kristopaitis, T; Lee, JM; Petruzzelli, GJ; Thomas, C | 1 |
Bloom, GS; Luca, FC; Vallee, RB | 1 |
6 other study(ies) available for paclitaxel and Pituitary Neoplasms
Article | Year |
---|---|
Fatal Candida septic shock during systemic chemotherapy in lung cancer patient receiving corticosteroid replacement therapy for hypopituitarism: a case report.
Topics: Adenoma; Adrenal Cortex Hormones; Aged; Antineoplastic Combined Chemotherapy Protocols; Candidemia; Carboplatin; Fatal Outcome; Febrile Neutropenia; Humans; Hypophysectomy; Hypopituitarism; Lung Neoplasms; Male; Paclitaxel; Pituitary Neoplasms; Shock, Septic | 2014 |
[Central diabetes insipidus caused by pituitary metastasis of lung cancer].
Topics: Adenocarcinoma; Aged; Antidiuretic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Docetaxel; Humans; Lung Neoplasms; Male; Paclitaxel; Pituitary Neoplasms; Radiosurgery; Taxoids | 2005 |
Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carboplatin; Cerebral Ventricle Neoplasms; Combined Modality Therapy; Consciousness Disorders; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Etoposide; Female; Gemcitabine; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Hypophysectomy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pituitary Neoplasms; Temozolomide; Thiotepa; Topotecan | 2008 |
Drugs that influence tubulin polymerization modulate thyrotropin-releasing hormone receptor number in AtT-20 cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Count; Cell Division; Colchicine; Kinetics; Mice; Paclitaxel; Pituitary Neoplasms; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone; Transfection; Tubulin; Tumor Cells, Cultured; Vinblastine | 1997 |
Malignant craniopharyngioma.
Topics: Adult; Carboplatin; Carcinoma, Squamous Cell; Craniopharyngioma; Female; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Paclitaxel; Pituitary Neoplasms; Radiotherapy; Tumor Suppressor Protein p53 | 2000 |
Identification of high molecular weight microtubule-associated proteins in anterior pituitary tissue and cells using taxol-dependent purification combined with microtubule-associated protein specific antibodies.
Topics: Alkaloids; Animals; Antibodies; Antineoplastic Agents, Phytogenic; Cattle; Cell Line; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Fluorescent Antibody Technique; Immunoassay; Mice; Microtubule-Associated Proteins; Molecular Weight; Paclitaxel; Pituitary Gland, Anterior; Pituitary Neoplasms | 1985 |